Risperdal Not Effective Treatment for Autism

>> Tuesday, February 24, 2009

One of the only FDA approved medications for autism has been proved to be ineffective against a placebo or sugar pill. That is just to bad. I had once wanted to try this with my kids, but the doctor would not let them try for his own reasons I guess. Autism Speaks announced initial results for the first industry-sponsored trial of the Autism Clinical Trials Network (ACTN), the Study of Fluoxetine in Autism (SOFIA). Neuropharm Group Plc., helped out in the research. They are a specialty pharmaceutical company focused on neurodevelopment disorders. You can read more about Risperdal being ineffective for autism with in the article. It is really nice to know that they are out there trying to keep our kids safe when medication seems the only road to take at a certain point in ones life.

Glitter Text Generator

Glitter Text Generator

1 special comments:

vanwolf March 20, 2009 at 7:53 PM  

your blog. Just wanted to point out that the study you quoted was not for risperdal but fluoxetine. I too am glad they are doing more trials on these meds.